Cryopreserved Fetal Liver Cell Transplants Support the Chronic Failing Liver in Rats with CCl4-Induced Cirrhosis

Autor: Barry Fuller, Alexander Y. Petrenko, O. V. Ochenashko, Nataliya A. Volkova, Alexander Y. Somov, Svetlana P. Mazur
Jazyk: angličtina
Rok vydání: 2006
Předmět:
0301 basic medicine
Liver Cirrhosis
Male
Pathology
Cirrhosis
Cryopreservation
law.invention
Mixed Function Oxygenases
Hepatic function
0302 clinical medicine
Cytochrome P-450 Enzyme System
Liver Function Tests
law
CCl4-induced cirrhosis
Carbon Tetrachloride
Rat liver function
Liver cell
Mitochondria
Survival Rate
Liver
Human
medicine.medical_specialty
Transplantation
Heterologous

Biomedical Engineering
CCL4
03 medical and health sciences
Hepatocyte transplantation
Fetus
Fetal Tissue Transplantation
medicine
Animals
Humans
Rats
Wistar

Transplantation
business.industry
Liver cell transplantation
Bioartificial liver device
Cell Biology
medicine.disease
Fetal liver cells
Rats
Disease Models
Animal

030104 developmental biology
Chronic Disease
Hepatocytes
business
030217 neurology & neurosurgery
Liver Failure
Popis: Hepatocyte transplantation is a promising method for supporting hepatic function in a broad spectrum of liver diseases. The aim of this work was to test the efficacy of human fetal liver cells to support the chronic failing liver in an experimental model of carbon tetrachloride (CCl4)-induced cirrhosis in rats. Liver cirrhosis was induced by intraperitoneal administration of CCl4 at a dose of 0.2 ml (50% v/v solution)/100 g body weight, twice a week for 3 months in rats. Ten days after stopping CCl4 administration (experimental day 0), rats received intrasplenic injection of cryopreserved fetal liver cells (FLC, 1 × 107 cells in 0.3 ml medium). As a cirrhotic control group, CCl4-induced cirrhotic rats were used with intrasplenic injection of an equal volume of medium alone. Animals were sacrificed on experimental day 15. Human fetal liver cell transplantation almost completely prevented the death of cirrhotic animals during the 2 weeks after treatment, while high ongoing mortality was seen in the cirrhotic control group. Cell transplantation into the spleen normalized total bilirubin and TBARSs levels and increased albumin levels in blood serum, as well as restoring mitochondrial function and liver detoxification function (assessed by cytochrome P450 contents and activity) compared with the activities seen in the cirrhosis control group. In parallel with this restoration of biochemical and functional liver indices, morphological patterns of liver recovery or regeneration after liver cell transplantation were demonstrated in day 15 samples by light microscopy. These were absent in the group that had received only medium alone.
Databáze: OpenAIRE